"esophageal foreign body" trang 2 - tải miễn phí từ tailieunhanh
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome
6    85    1
The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: Results from a retrospective study

The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: Results from a retrospective study
11    58    1
Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer
9    98    1
Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouraciloxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: The PROTECT-1402, randomized phase 2 trial

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouraciloxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: The PROTECT-1402, randomized phase 2 trial
7    93    1
Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma

Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma
12    53    1
Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma

Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma
7    42    1
Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma

Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma
11    56    1
Association of angiogenic factors with prognosis in esophageal cancer

Association of angiogenic factors with prognosis in esophageal cancer
11    85    1
Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis

Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis
8    34    1
Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma

Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma
6    92    1
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma

Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
7    47    1
Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma

Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma
10    55    1
Measuring telomere length for the early detection of precursor lesions of esophageal squamous cell carcinoma

Measuring telomere length for the early detection of precursor lesions of esophageal squamous cell carcinoma
8    54    1
Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas

Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas
10    54    1
Evaluation of clinical characteristics and lower esophageal sphincter pressure on high resolution manometry in achalasia patients after treatment

Evaluation of clinical characteristics and lower esophageal sphincter pressure on high resolution manometry in achalasia patients after treatment
5    84    2
Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: A retrospective multicenter study

Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: A retrospective multicenter study
10    60    1
Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis

Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis
16    56    1
Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers

Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers
11    59    1
Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)

Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)
12    52    1
Treatment outcomes of esophageal cancer in Eastern Africa: Protocol of a multi-center, prospective, observational, open cohort study

Treatment outcomes of esophageal cancer in Eastern Africa: Protocol of a multi-center, prospective, observational, open cohort study
13    69    3